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AbstrACt
Introduction Quality of life of people with advanced 
dementia living in nursing homes is often suboptimal. 
Family caregivers can feel frustrated with limited 
contact with their relatives, which results in visits that 
are perceived as stressful and not very meaningful. Few 
psychosocial interventions are specifically developed 
for people with advanced dementia, and actively involve 
family caregivers or volunteers. Also, interventions usually 
stop when it becomes difficult for people to participate. 
The Namaste Care Family programme aims to increase 
the quality of life of people with advanced dementia, and 
improve family caregiving experiences through connecting 
to people and making them comfortable.
Methods and analysis Our study will evaluate the effects 
of the Namaste Care Family programme on quality of 
life of people with advanced dementia living in nursing 
homes and family caregiving experiences using a cluster-
randomised controlled trial. Longitudinal analyses will be 
performed taking into account clustering at the nursing 
home level. Both a cost-effectiveness and a cost-utility 
analysis from a societal perspective will be performed. 
We will modify the Namaste Care Family programme to 
increase family and volunteer involvement in ongoing and 
end-of-life care. Data collection involves assessments by 
family caregivers, nursing staff and elderly care physicians 
using questionnaires, and observations by the researchers 
at baseline and multiple times over 12 months. The last 
questionnaire will be sent up to month 24 after the death 
of the person with dementia. During semistructured 
interviews, the feasibility, accessibility and sustainability of 
the Namaste Care Family programme will be assessed.
Ethics and dissemination The study protocol is 
approved by the Medical Ethics Review Committee of 
the VU University Medical Center in Amsterdam (protocol 
no. 2016.399) and registered with the Nederlands Trial 
Register (NTR5692). The findings will be disseminated 
via publications in peer-reviewed journals, conference 
presentations and presentations for healthcare 
professionals where appropriate.
trial registration number NTR5692.
IntroduCtIon
background and rationale
Currently, 47.5 million people are living with 
dementia worldwide and the prevalence is 
projected to double every 20 years.1 Dementia 
is a progressive, life-limiting disease without 
an imminent cure or effective drug treat-
ment. Although a number of psychosocial 
interventions are available for people with 
dementia, few specifically target people with 
advanced dementia.2 Moreover, the end-of-
life phase is usually not included. Experts in 
strengths and limitations of this study
 ► The Namaste Family Care programme offers a novel 
approach to involve family caregivers and volunteers 
in care of nursing home residents with advanced de-
mentia and at the end of life that is subjected to a 
thorough (cost-)effectiveness and process evalua-
tion during its implementation.
 ► A large sample of at least 192 people with advanced 
dementia living in at least 16 nursing homes—
equally randomised to the intervention group and 
the usual care group—will be recruited to allow 
for detection of a possible meaningful difference in 
change of quality of life and family experiences.
 ► A design with multiple follow-up assessments per 
resident is used to increase power, to enable longi-
tudinal analyses and to allow for analyses of media-
tors and moderators.
 ► Nursing staff, elderly care physicians and fami-
ly caregivers cannot be blinded to the treatment 
condition due to the nature of the intervention pro-
gramme, but parts of the observations are blinded.  on
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dementia and palliative care endorse the benefits of palli-
ative care in advanced dementia.3 It is therefore of vital 
importance to identify psychosocial interventions which 
at least sustain, but preferably improve, the quality of life 
of people with (advanced) dementia and to develop and 
provide high-quality end-of-life care.
When people with dementia are admitted to a long-
term care facility, most of the care is taken over by profes-
sionals. However, previous research has shown that the 
burden for family caregivers (eg, family, relatives, friends) 
often remains high,4 and family caregivers find it difficult 
to connect meaningfully with people with dementia in 
the advanced stages. Family caregivers can become frus-
trated if contact with the person with dementia is limited 
by aphasia and cognitive impairment, resulting in expe-
riencing their visits as stressful and not very meaningful.5 
Also, most people with dementia manifest neuropsychi-
atric symptoms such as anxiety, restlessness, agitation and 
aggression over the course of the disease. The prevalence 
of neuropsychiatric symptoms increases as the disease 
progresses,6 7 and challenging behaviours commonly 
occur in nursing home residents with advanced dementia 
and even—although possibly to a lesser extent—at the 
end of life.8 9 Neuropsychiatric symptoms are considered 
the most distressing, difficult and burdensome aspects of 
caring for people with dementia.10–12
With the progression of dementia, difficulties in 
communication and in performing activities of daily 
living occur. Therefore, people with advanced dementia 
become less engaged with their environment and with 
those around them, and as a result, quality of life may 
decrease.13–16 People with advanced dementia may be 
isolated in their rooms or hallways as they cannot partic-
ipate anymore in the regular activities that are offered 
in the nursing home.17 18 The presence of neuropsychi-
atric symptoms makes it more difficult to engage people 
with advanced dementia in meaningful activities and may 
further increase the risk of isolation. These behaviours 
may arise from unmet needs.19–21 Psychosocial needs of 
people with dementia, such as the need to engage in daily 
individualised activities and care, should therefore not 
be ignored in long-term care.22 Also, evidence supports 
that psychosocial interventions can improve a number of 
outcomes in people with dementia, including neuropsy-
chiatric symptoms.23–25
Psychosocial interventions for people with dementia 
living in nursing homes often do not involve family care-
givers or lack evaluation of the effects on family care-
giving experiences. Ideally, a programme that involves 
family caregivers should be easy to implement, while it 
does not require extensive resources and can be tailored 
to the individual, as personalised interventions have been 
proven to be the most effective interventions for nursing 
home residents with more severe dementia, and particu-
larly for people with challenging behaviours.26
An intervention which may meet these requirements is 
a programme called Namaste Care,27 a daily multidimen-
sional care programme with psychosocial, sensory and 
spiritual components that incorporates person-centred 
and palliative care approaches. By respecting each person 
with dementia as a unique individual, the programme 
pays attention to the individual’s dignity until death.28 By 
engaging people with dementia in meaningful activities 
on a daily basis, the programme attends to their psycho-
logical, bodily and spiritual needs.27 29 30 Namaste Care is 
designed to reach people with dementia who are socially 
withdrawn and who no longer benefit from the regular 
recreational social and group activities, have severe cogni-
tive impairments, require care with all activities of daily 
living, have limited verbal abilities and spend a lot of time 
sleeping.27 29 Namaste Care is also deemed beneficial for 
people with behavioural symptoms of dementia.29 It aims 
to increase the quality of life of people with advanced 
dementia who live in long-term care facilities. There are 
indications that the programme successfully improved 
the lives of people with advanced dementia and their 
families at no extra healthcare costs.30–32 For example, in 
the UK, implementation of the programme was achieved 
with only modest expenditures and no change in staffing 
levels.30 Further, it reduced behavioural symptoms of 
dementia and the use of psychotropic medication in 
people with dementia.29 33 34
Additional research about the effects of Namaste 
Care is needed. Although less behavioural symptoms of 
dementia have been reported and qualitative work indi-
cated improved quality of life of people with advanced 
dementia,29 30 34 35 these outcomes have not yet been 
tested in a large sample with a randomised control group. 
Furthermore, when effective, we need to identify the 
effective elements of the programme and whether the 
programme is more effective in specific subgroups. Also, 
it is important to assess the impact on family caregiver-re-
lated outcomes and evaluate cost-effectiveness from a 
societal perspective. This study will contribute in fulfilling 
some of these gaps in the current knowledge about the 
effects of Namaste Care and helps to further improve and 
disseminate the programme. This is important as Namaste 
Care has the potential to positively change how end-of-life 
care is provided to people with advanced dementia.
objectives
The primary objective of this cluster-randomised 
controlled trial will be to examine the effectiveness of the 
Namaste Care Family programme, an adapted version 
of the original Namaste Care, on (1) the quality of life 
of people with advanced dementia living in nursing 
homes and on (2) caregiving experiences of their family 
caregiver. The adaptations of Namaste Care include an 
emphasis on family caregivers and volunteers providing 
the care in collaboration with nursing staff, and more 
explicit and elaborate incorporation of end-of-life care. 
The secondary objects include (3) assessing the cost-ef-
fectiveness of the programme compared with usual 
care; (4) examining the effects of Namaste Care Family 
programme on discomfort, comfort in dying, behavioural 
symptoms of dementia, psychotropic medication use and 
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intercurrent health problems in nursing home residents 
with dementia; (5) assessing the effects of Namaste Care 
Family programme on family caregiver burden, guilt 
and conflict in caregiving, and (anticipatory) grief in 
family caregivers; (6) examining the effective elements 
of the programme; (7) defining subgroup(s) in which 
the intervention or elements are more effective; and 
(8) conducting a process evaluation to assess feasibility, 
accessibility and sustainability of the Namaste Care Family 
programme.
MEthods And AnAlysIs
We will conduct a cluster-randomised controlled trial. A 
cluster-randomised design was chosen because the inter-
vention is structured around groups of residents rather 
than individuals and it requires a different way of working 
by the nursing staff, and to minimise contamination. 
The unit of randomisation will be the nursing home 
or nursing home organisation. Data will be collected 
between May 2016 and December 2018 in the Nether-
lands. The study was registerted with the Nederlands Trial 
Register (NTR5692). 
recruitment of nursing homes
The study will take place in Dutch nursing homes. In the 
Netherlands, a nursing home is a facility with a domes-
tic-styled environment that provides 24-hour functional 
support and (medical) care for persons who require assis-
tance with activities of daily living and who often have 
complex health needs. Although postacute rehabilita-
tion may be provided in the nursing home, care is often 
long term and often includes palliative care.36 Dutch 
nursing homes employ their own multidisciplinary teams, 
consisting of an elderly care physician (a specialised 
physician who combines competencies of a general prac-
titioner with those of a geriatrician) and various other 
professionals (eg, nursing staff (eg, registered nurses and 
certified nursing assistants), psychologist, physiotherapist, 
dietician).37 There are long-stay departments specifically 
for residents with dementia, so-called psychogeriatric 
wards. At least 16 nursing homes with a psychogeriatric 
ward will be recruited for the current study. Nursing 
homes should be willing to offer the Namaste Care Family 
programme for at least 2 years.
We will send the manager of the nursing home an 
email with information about the study and the Namaste 
Care Family programme, and an invitation to participate 
in the study. After 2 weeks, a follow-up telephone call 
will be made to enquire whether there is an interest to 
participate. Reasons for not wanting to participate will be 
recorded. If there is interest, a meeting with the manager 
and/or other staff members will be scheduled to further 
discuss the aims of the study and the Namaste Care Family 
programme. When the nursing home decides to partici-
pate in the study, the manager will be asked to fill in a short 
questionnaire to assess the characteristics of the nursing 
home. Randomisation to the Namaste Care Family 
programme or the usual care group will be performed 
(see Randomisation procedure section for more details) 
and an individualised schedule is discussed to plan the 
procedural steps of the study (who will do what, when and 
where). Finally, the research team will organise a meeting 
in the nursing home to inform all staff about the study 
and the Namaste Care Family programme. The manager 
will also receive templates of leaflets and other materials 
to inform staff about the study.
randomisation procedure
Included nursing homes will be matched on various 
criteria that might impact the effects of the programme 
on outcome measures based on the questionnaire filled 
in by the manager. We will match nursing homes on 
volume of psychosocial programmes and programmes 
involving family caregivers in the care for the person with 
dementia. We will further take into account whether or 
not the ward is part of a small-scale living arrangement, 
and situated in a rural versus urban area as family support 
is likely to be a greater part of social life in more rural 
areas of the Netherlands. Furthermore, we will match on 
the number of residents on a ward and the manager’s 
perceived influence of the nursing home’s religious affil-
iation, as this was found to be independently associated 
with people with dementia dying more peacefully.38
Possible matches will be judged for appropriateness 
by three researchers (HJAS, KJJ, JTvdS). Successfully 
matched pairs of nursing homes will be randomised 
with one nursing home being allocated to the interven-
tion condition and the other to the usual care condition. 
Randomisation is performed by a statistician who is not 
involved in recruitment or data collection (PMvdV). Due 
to the nature of the intervention, the group allocation 
cannot be masked.
recruitment of participants
After randomising the nursing home to a treatment condi-
tion, the recruitment of participants within the nursing 
home will start. Within each nursing home, nursing staff 
will be asked to indicate which residents with advanced 
dementia and/or their family caregivers may benefit from 
the Namaste Care Family programme. They are residents 
with advanced dementia unable to participate in the 
regular activity programme and residents with moderate 
dementia with behavioural symptoms of dementia, having 
family caregivers understanding the Dutch language and 
who are willing and able to fill in questionnaires.
The family caregivers of eligible residents will be sent an 
invitation letter from the nursing home, a consent form 
and a participant information letter. The family caregiver 
will be asked to sign and return an informed consent form 
to the research team via a pre-stamped envelope. After 
2 weeks, a reminder will be sent. For study participation, 
written informed consent given by the family caregiver will 
be required. All nursing homes will be offered a ‘family 
meeting’ at their location, organised by the research team, 
to inform family caregivers and volunteers about the study 
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and the programme. Participants will have the right to with-
draw from participation at any time if they wish so. No finan-
cial incentive to participate will be provided.
Intervention
The nursing homes in the intervention group will implement 
the Namaste Care Family programme, a modified version 
of the original Namaste Care.27 The adaptations include 
an emphasis on family caregivers and volunteers providing 
the care in cooperation with the nursing staff, and more 
explicit and elaborate incorporation of end-of-life care. We 
have developed two manuals about the Namaste Care Family 
programme, one for management and one for nursing staff, 
family caregivers and volunteers, based on Simard’s book27 
and the British toolkit for implementing Namaste Care.39 
We will make a summary available of the parts that are 
specific to the adapted Family form of the intervention after 
completing the study.
Namaste Care Family, similar to the original Namaste 
Care, is a 7-day-a-week programme, intended to be offered 
in 2-hour sessions, twice a day. The sessions take place in a 
calm home-like room, the ‘Namaste room’, with soft music 
or nature sounds and pleasant scents, and without external 
distractions or interruptions. Each session starts with person-
ally greeting each resident when entering the Namaste 
room. Each resident is comfortably seated and screened for 
signs of pain. Nutritious, appetising foods and drinks are 
offered frequently to increase hydration and raise caloric 
intake. During the sessions, meaningful activities and multi-
sensory stimulation are integrated with person-centred care 
and reminiscence. Extra personal care (massages; washing 
the face, hands and feet; grooming; nail care) is offered 
during the sessions to facilitate an experience of gentle, 
caring touch. The session ends with thanking each resident 
for their presence in the Namaste session and a personalised 
goodbye.27 30
Nursing staff and volunteers in the intervention group will 
receive a 2-hour training from the research team in which 
they will learn about the principles of the Namaste Care 
Family programme, the purpose and the benefits of the 
programme for people with dementia, their families and 
staff, and will be offered tools to develop a plan to imple-
ment, evaluate and sustain the programme in their nursing 
home. The training will take place after the baseline assess-
ment. One month after the start of the Namaste Care Family 
programme, the manager or ‘Namaste coordinator’ (ie, 
person in charge of all practical aspects of the programme in 
the nursing home) in each nursing home will be contacted 
by the research team to evaluate the first month of the 
programme and, if they prefer, to discuss questions and 
problems. The primary researcher (HJAS) will participate 
in or observe at least two Namaste sessions in each nursing 
home, one in the first 3 months and one after 6 months from 
the start of the programme, and will evaluate these sessions 
afterwards with the nursing staff and will provide feedback 
to improve the implementation of the programme when 
needed.
Patient and public involvement
Patients (ie, people with advanced dementia) were not 
involved in the research design. The research protocol 
was reviewed by family caregivers and people with mild 
dementia. Family caregivers were consulted to select the 
best questionnaires for measuring positive caregiving 
experiences for family caregivers of people with advanced 
dementia. Family caregivers will be asked to review the 
participant information letter that will be used for the 
recruitment. Also, family caregivers and volunteers will be 
invited to participate in the Namaste sessions. Family care-
givers will receive a newsletter every 3 to 4 months with an 
update of the progress of the study and, in time, the results 
of the study.
data collection
Figure 1 outlines the trial recruitment and data collec-
tion process. Table 1 shows an overview of the instruments 
that will be used for assessment. Questionnaires will be 
made available online or on paper, depending on the 
preferences of the respondent and the nursing home. 
If preferred, the research team will assist in filling out the 
questionnaires.
The manager of the nursing home will assign each 
resident to a member of the nursing staff who knows the 
resident well and can fill in the questionnaires about the 
resident throughout the study. The elderly care physi-
cians will also complete questionnaires about the resi-
dents and they may be assisted by a nurse practitioner. 
All respondents will be asked to fill in the questionnaires 
within 2 weeks. If needed, a reminder to fill in the ques-
tionnaire will be sent after 2 weeks.
Observations will be performed by trained research 
assistants who are unfamiliar with the residents and the 
assessments will last approximately 10 min per resident. 
The primary researcher (HJAS) and the project coor-
dinator will train all research assistants with an instruc-
tional video and set of examples. The research assistants 
will be instructed to plan observations, if possible, at the 
same time for each assessment during daytime, but not 
during meals or shortly after burdensome procedures 
(eg, physiotherapy, toileting or transfers). Each resident 
will be observed by the same observer at each assess-
ment whenever feasible. For the intervention group, 
standard observations after the baseline assessment will 
be conducted during a Namaste session. This does not 
allow for blinding the research assistants for the treat-
ment group. To minimise bias, the research assistants will 
not be told any details about the intervention or study 
goals. We will also plan an additional observational assess-
ment at least 3 months after the start of the Namaste Care 
Family programme after a Namaste session, performed 
by a blinded research assistant who is new to the team. 
To monitor inter-rater reliability, 10% to 20% of the 
observations will be scored by two research assistants 
independently.
 o
n
 28 January 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-025411 on 15 October 2018. Downloaded from 
5Smaling HJA, et al. BMJ Open 2018;8:e025411. doi:10.1136/bmjopen-2018-025411
Open access
Primary outcome measures
Quality of life
The Quality of Life in Late-Stage Dementia (QUALID)40 41 will 
be used to assess quality of life of the person with dementia. 
The QUALID is a brief, proxy informant-based question-
naire consisting of 11 domain-specific items. Each item has 
five response options indicating the frequency of concrete 
and observable mood and performance items, such as 
smiles, enjoys eating or facial expression of discomfort, over 
the last week. Summed scores can range from 11 to 55 with 
lower scores indicating better quality of life. The QUALID, 
including the Dutch translation, has good psychometric 
properties.40 42 43
Positive caregiving experiences
To better understand the positive aspects of caregiving, we 
will use two instruments to measure family caregivers’ care-
giving experiences, one focusing specifically on positive 
experiences and the other focusing on gains in dementia 
caregiving.
Figure 1 Study flow diagram. 
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The Positive Experiences Scale (PES)44 for family care-
givers of people with dementia will be used to measure 
positive experiences by family caregivers. The PES consists 
of hierarchically ordered items which vary from intrinsic 
satisfaction (‘Caring for my loved one makes me feel good’) 
and relational enhancement (‘During the period that I have 
been providing care, my loved one and I have grown closer 
(quality of our relationship is better now)’) to improvement 
of competence (‘As a result of providing care, I have learnt 
new things myself’) and social enhancement (‘As a result of 
providing care, I have met new people’). Items are scored on 
a three-point Likert scale (agree, don’t agree/don’t disagree, 
disagree). In addition to the six items that have been iden-
tified as suitable for caregivers of people with dementia in 
previous research, we use a seventh PES item ‘Helping has 
made my relationship with my family and friends closer’, as 
we expect that the Namaste Care Family programme might 
have a positive influence in this regard. The PES has good 
psychometric properties.44
The Gain in Alzheimer Care Instrument45 will be used 
for measuring family caregivers’ gains in dementia care-
giving. The scale has 10 items that make up three compo-
nents: (1) personal growth, (2) gains in relationships and 
(3) higher-level gains. Items are scored on a Likert scale 
from 0 (disagree a lot) to 4 (agree a lot). Summed scores 
can range from 0 to 40, with higher scores indicating 
higher gains. The instrument has good psychometric 
properties.45
secondary outcome measures
Discomfort
The well-tested Discomfort Scale–Dementia of Alzheimer 
Type (DS-DAT)46 will be used to observe discomfort in 
the person with dementia. The scale uses duration and 
frequency of seven negative (eg, negative vocalisation) and 
two positive (eg, relaxed body language) behaviours. Each 
item is scored 0–3 and summed scores range from 0 to 27 
with higher scores referring to more discomfort. The Dutch 
DS-DAT has good psychometric properties.47
Comfort (in dying)
The End-of-Life in Dementia—Comfort Assessment in 
Dying48 comprises 14 items and consistently refers to the 
quality of dying.49 This simple tool, developed for evalua-
tion retrospectively after death, had the best psychometric 
properties and feasibility to measure quality of dying in 
long-term care in a combined US–Dutch study.50 A higher 
total score indicates a better comfort level.
The nine items of the End of Life in Dementia—Symptom 
Management (EOLD-SM)48 quantify the frequency a resi-
dent experiences the following nine symptoms and signs: 
pain, shortness of breath, depression, fear, anxiety, agitation, 
calm, skin breakdown and resistance to care. Frequency is 
quantified on a six-point Likert scale ranging from 0 to 5 as 
follows: daily, several days a week, once a week, 2 or 3 days 
a month, once a month, never. The original timeline was 
‘previous 90 days’, but we will adapt this timeframe to ‘last 
month’. The scale ranges from 0 to 45 with higher scores 
indicating better symptom control. The EOLD-SM has 
moderate to good psychometric properties.48 51
Behavioural symptoms of dementia
The Neuropsychiatric Inventory Questionnaire (NPI-
Q)52 will be used to measure 12 behavioural symptoms of 
dementia over the past month, namely delusions, halluci-
nations, dysphoria, anxiety, agitation/aggression, euphoria, 
disinhibition, irritability/lability, apathy, aberrant motor 
activity, night-time behaviour disturbances and eating abnor-
malities. Nursing staff are asked to indicate ‘yes’ or ‘no’ to 
each screening question, and to subsequently rate the pres-
ence of symptoms in terms of severity on a three-point scale 
(mild, moderate, severe). The total NPI-Q severity score 
ranges from 0 to 36 and represents the sum of individual 
symptom scores. Distress associated with the symptom will be 
measured for symptoms that are present with the NPI-Dis-
tress Scale (NPI-D) with scores ranging from 0 ‘not emotion-
ally stressful’ to 5 ‘extremely stressful’. The total NPI-D sum 
score ranges from 0 to 60. We will also include subscales of 
the behavioural scales as outcome measures. The NPI-Q 
provides a reliable, valid assessment of neuropsychiatric 
symptoms.52 53 However, there is less evidence for validity of 
subscales compared with total scores.54
Medication use and health problems
We will measure intercurrent health problems (sentinel 
events) in the past 6 months: pneumonia, (other) febrile 
episode, new eating or drinking problem, and other new 
major medical illness or event (eg, hip fracture, stroke, 
gastrointestinal bleed, cancer).55 The health condition of 
the resident, including incontinence, comorbid diseases, 
nutritional and hydration status, and delirium,55 will also 
be measured. A clinical judgement of illness severity will be 
assessed on a scale ranging from 1 (‘not ill’) to 9 (‘mori-
bund’).56 To assess infections, dehydration and weight loss, 
we will use items from the InterRAI-Minimum DataSet.57 58 
The elderly care physician will be requested to provide a list 
of all medication used in the week before each assessment.
Caregiver burden
We will use the shortened seven-item version of Zarit’s 
well-tested caregiver burden interview (ZBI).59 60 Items 
are scored on a five-point scale, with a cut-off score of ≥13 
considered as a clinically significant burden.59 We will also 
use a Visual Analogue Scale (VAS)61 based on the Self-Rated 
Burden scale (SRB)62 for assessing the burden of family 
caregiving. The family caregiver will be asked to indicate 
on the VAS how burdensome they feel in caring for the 
person with dementia. The VAS is anchored at 0 ‘not at 
all straining’ (not hard at all) and 10 ‘much too straining’ 
(much too hard).
Guilt and conflict in caregiving
The Family Perceptions of Caregiving Role will be used 
to measure multiple dimensions of family member 
distress associated with an institutionalised relative with 
dementia.63 Response options form a seven-point agree-
ment scale.63 64 We will only use the subscales ‘conflict with 
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staff over caregiving’ (10 items) and ‘guilt from perceived 
failure in caregiving’ (5 items), as increased caregiver 
involvement has been associated with increased feelings 
of guilt and conflict with staff in an intervention helping 
family caregivers create meaningful roles for themselves in 
long-term care settings.64
(Anticipatory) grief
Grief will be assessed with the pre-loss and post-loss versions 
of the Prigerson’s Prolonged Grief Disorder (PGD) 
Scale.65 66 The post-loss version of the PGD Scale comprises 
11 items from the Inventory of Complicated Grief-Re-
vised that were slightly modified to resemble the proposed 
criteria for PGD.66 Family caregivers rate the occurrence of 
symptoms in the past month on a five-point scale ranging 
from ‘never’ to ‘always’. We modified the Dutch PGD-1165 
to refer to the pre-loss period while retaining the meaning 
of the items. Two items from the English pre-loss version 
that were not congruent with the Dutch post-loss items 
were translated into Dutch and added to the Dutch pre-loss 
questionnaire. This resulted in a 13-item pre-death grief 
scale asking family caregivers how often they experience 
distressing grief symptoms related to yearning, bitterness, 
interpersonal disengagement and a sense of meaningless-
ness. The items are summed to result in an overall severity 
score.
Measures to evaluate mediators
An effect of the intervention on quality of life and 
family caregiving experiences may be achieved through 
person-centredness of care, frequency and quality of the 
family visits, engagement of the person with dementia, 
received dose of the intervention and level of implementa-
tion of the Namaste Care Family programme (see table 1).
Challenging behaviour may be theorised as due to unmet 
psychosocial needs which may be met by person-centred 
caregiving. A person-centred caring environment (eg, ‘A 
place that feels homely’)67 68 was found to improve resi-
dents’ quality of life and increased family involvement while 
it decreased perceived care burden.69 The involvement of 
family caregivers in dementia care was found to reduce 
residents’ challenging behaviour, improve the residents’ 
quality of life as well as the quality of life of their family care-
givers.70–72 Family caregiver perceptions of a better quality 
of their visits to the person with dementia may mediate the 
effects on the primary outcomes. Also, engagement with 
stimuli and structured activities has been found to improve 
affect and decrease behavioural symptoms of dementia.17 
Finally, the dose of the intervention and the fidelity of 
implementation may also mediate effects in the interven-
tion group.
Person-centredness
Person-centredness of caring will be assessed using the 
Person-centred Climate Questionnaire—family version 
(PCQ-F).73 The PCQ-F is similar in content to the previously 
published patient version,74 but we changed the perspective 
to a proxy perspective. The 17 items of aspects about care 
climate are rated on a six-point Likert scale ranging from 0 
(‘No, I disagree completely’) to 5 (‘Yes, I agree completely’). 
The total score ranges from 0 (lowest person-centred care) 
to 85 (highest score for person-centred care).
Family visits
The frequency and average time of a regular visit by the 
family caregiver will be measured. In the intervention 
group, we will also assess if and how often the family care-
giver participates in Namaste sessions.
The quality of family visits will be measured with the 
Family Visit Scale for Dementia (FAVS-D).75 The FAVS-D 
comprises 14 items rated on a five-point scale (‘strongly 
disagree’, ‘disagree’, ‘neutral’, ‘agree’ and ‘strongly agree’). 
A total score can be calculated with a higher score indi-
cating a higher quality of the visits.
Engagement
We will measure positive vocalisations, an important 
dimension of engagement.76 Positive vocalisation has been 
operationalised after pilot testing observation of positive 
vocalisation as any verbal, vocal utterance or noise with a 
positive quality, such as sounds expressing happiness, joy 
and/or satisfaction, a high-pitched noise with a definite 
pleasant sound, repeating the same words with a joyful tone, 
expressing joy, pleasure, happiness or satisfaction (eg, ‘I am 
happy’, ‘This cake is my favourite’, laughing, singing). We 
will score the presence of positive vocalisations for 7 min. A 
sum score can be calculated and examples of positive vocal-
isations will be noted when expressed.
Fidelity of programme implementation
Nursing staff will be asked to register the activities offered 
during each Namaste session for individual participants and 
the time each participant spends in the Namaste session, 
so an overview of elements implemented at an individual 
level and a Namaste dose per participant can be made. 
The researchers will visit at least two Namaste sessions in 
each nursing home, once at the start of the programme 
and after at least 6 months, during which the quality of the 
implementation will be monitored. We will also develop a 
10-item checklist to score the level of implementation of 
Namaste components on a three-point scale. An implemen-
tation sum score with a possible range from 0 to 20 can be 
composed by summing the items, with higher scores indi-
cating a better implementation of the Namaste Care Family 
programme.
Measures to evaluate moderators
Moderators modify the effect of the intervention, indi-
cating subgroups in which it is more or less effective. The 
baseline levels of agitation and apathy of the person with 
dementia and initial caregiver burden will be examined as 
potential moderators for quality of life and positive care-
giving experiences, respectively. For example, it may be 
more difficult to experience satisfaction from caregiving 
when caregivers perceived their role as a burdensome expe-
rience.77 Agitation and apathy in people with dementia are 
associated with caregiver frustration and a reduced quality 
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of life. People with dementia with agitation or apathy may 
benefit more from the programme, as psychosocial inter-
ventions based on person-centred care and with elements 
of sensory stimulation, offering activities, and teaching the 
family to connect to the person with dementia are effective 
in reducing agitation and apathy in people with advanced 
dementia.78 79
Other possible moderators in our study are sociodemo-
graphics (eg, gender and personality), pain and satisfaction 
with care. Gender and personal characteristics impact the 
caregiving experience.77 80 Planned reporting of treatment 
outcomes by specific subgroups, such as gender,80 is being 
encouraged to tailor interventions to specific subgroup 
needs. The Namaste Care Family programme seeks to 
enrich quality of life through shared activity and increased 
social interaction. More personal care and touch are used 
to connect to the person with dementia. The effects of the 
Namaste Care Family programme on quality of life may 
therefore differ depending on the previously expressed 
preferences for touch and whether the person with 
dementia was socially engaged.81 One of the UK studies 
found Namaste Care effective in improving behaviour 
only in homes with adequate pain control in place, which 
suggests pain is a moderator of programme effectiveness.34 
Family caregivers who are satisfied with the care may experi-
ence more positive experiences. Satisfaction with care may 
also be a subjective indicator of quality of care and thus 
impact the quality of life the residents.
The presence and severity of agitation and apathy in the 
people with dementia will be assessed using the NPI-Q.52 
Caregiver burden is measured using the ZBI59 60 and SRB.61 
These instruments have been described in more detail 
under Secondary outcome measures section.
Sociodemographics: gender and personality
Sociodemographic information of the family caregiver and 
person with dementia will be assessed using items of the 
Older Persons and Informal Caregivers Survey–Minimum 
Data Set (TOPICS-MDS).61 Additionally, we will include the 
two items for personality indicating the family caregiver’s 
perception of the person with dementia previous prefer-
ence for touch (ie, whether or not the person liked to be 
touched) and being socially engaged (ie, whether or not 
the person liked group activities).
Pain
The five-item Pain Assessment in Advanced Dementia82 
will be used to assess pain in the person with dementia. 
The items are scored during a direct 2 min observation on 
a three-point scale. A sum score can be calculated with a 
higher score indicating higher probability of pain (possible 
range 0–10). A validated cut-off of 2 indicates probable 
presence of pain.83
Satisfaction with care
The family caregiver’s satisfaction with care will be 
measured with the 10-item End-of-Life in Dementia–Satis-
faction With Care (EOLD-SWC).48 Items are scored on a 
four-point scale (‘strongly disagree’ to ‘strongly agree’). 
The EOLD-SWC has the best psychometric properties and 
feasibility for families to evaluate the quality of end-of-life 
care49 50 and can also be used when a person is not at the 
end-of-life stage. Higher total scores indicate higher levels 
of satisfaction with care.
other clinical characteristics
The severity of dementia will be measured with the seven-
item Bedford Alzheimer Nursing Severity-Scale (BANS-
S).84 Item scores range from 1 to 4, and total scores range 
from 7 to 28, with a cut-off of 17 or higher indicating severe 
dementia.85 Type of dementia and Mitchell’s Advanced 
Dementia Prognostic Tool86 will be used to calculated a 
12-month mortality risk score.
Cost-effectiveness
Costs will be measured from a societal perspective 
according to a Dutch standardised data collection tool for 
older people, the TOPICS-MDS.61 We will use a bottom-up 
micro-costing approach to estimate intervention costs 
which will include costs of supplies for Namaste Care 
Family programme, any change (increase or decrease) 
in staff time, and family and volunteer time investments. 
Healthcare costs will include medication, hospitalisation, 
and emergency room and specialist visits. For the valu-
ation of healthcare use, standard prices published in the 
Dutch costing guidelines will be used.87 Medication will be 
valued using prices of the Dutch National Healthcare Insti-
tute.88 Informal care spent by family excluding time spent 
on the Namaste Care Family programme will be assessed 
and valued using the Dutch standard price. Societal costs 
will be related to the main effect measures of quality of life 
as measured by the QUALID,40 41 quality-adjusted life years 
(QALY) and positive caregiving experiences measured by 
the PES44 in the economic evaluation.
QALYs will be calculated using the Dutch tariff for the 
EuroQol-5D (EQ-5D).89 The EQ-5D is a five-item objective 
measure of health status in which items (mobility, self-care, 
usual activities, pain/discomfort and anxiety/depression) 
are described by choosing one out of three possible degrees 
of impairment/severity (ie, no, some, extreme). The instru-
ment also includes a VAS anchored at 0 ‘worse imaginable 
health state’ and 100 ‘best imaginable health state’. The 
EQ-5D has been shown to be responsive, internally consis-
tent and reliable when used for people with dementia or 
cognitive impairment.90 91
data management
The questionnaires and observations will be coded with 
unique identification numbers to guarantee privacy. A 
unique identifier will be assigned to all participants (eg, 
people with dementia, family caregivers, nursing staff, 
elderly care physicians and research assistants) and nursing 
homes, with linkage keys to be stored separately from the 
data. Respondents can choose to fill in questionnaires digi-
tally or on paper. The data from the digital questionnaires 
will be converted into a SPSS data file. The data from any 
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paper questionnaire will be entered directly into a SPSS 
database by research assistants. We will subject 10% of the 
latter data to a random audit by a second researcher to test 
the accuracy of data entry. We will store all study data on a 
password-protected drive that is only accessible to members 
of the research team.
sample size
The standard power calculations to detect a relevant 
difference in the primary outcomes—quality of life of 
the persons with dementia and positive caregiving expe-
riences—indicated sufficient power with eight nursing 
homes per group (16 in total) and 14 residents per home 
for QUALID and PES outcomes. We used the mean (M) 
and SD as calculated in previous work validating the Dutch 
version of the QUALID in nursing home residents with 
advanced dementia (M=7.5, SD=4.9).41 For the PES, it was 
analysed and provided for the subgroup of family caregivers 
with dementia (M=2.9, SD=1.9).92 Clinically relevant differ-
ences in means were defined as 1.5 on the PES and 4 on the 
QUALID.
Simulations were performed considering QUALID as 
the primary outcome and accounting for a maximum of 
four assessments per person. Power was based on the test 
for an interaction between time of measurement and inter-
vention, taking into account the three-level structure with 
measurements within persons within nursing homes. The 
SD (total of between subjects and between nursing homes) 
for QUALID and the within-subject correlation were first 
estimated using the six consecutive QUALID assessments 
available from the Dutch End of Life with Dementia Study 
(DEOLD) dataset,55 selecting patients with severe dementia 
(BANS-S score of 17 or higher). Different scenarios were 
considered where the SD and within-subject correlation 
were varied around these estimates. Additionally, various 
scenarios for attrition over time were considered.
Assuming, conservatively, that the full effect of the inter-
vention occurs after 3 months, SDs between 6 and 8, up to 
four consecutive follow-up assessments with several drop-out 
scenarios to accommodate mortality differential for initial 
QUALID score and based on an estimated survival of half 
of these patients in a year follow-up as in DEOLD, we found 
that the power to detect a difference of 4 QUALID points 
change between the intervention and usual care groups was 
between 83% and 100% for all 32 scenarios for 8 homes 
per group (16 in total) and an average of 12 residents per 
home. For 7 homes per group and 10 residents per home, 
the power varied between 70% and 90.5%, with 28 of 32 of 
scenarios presenting with over 80% of power.
However, for mediator analyses with an intracluster 
correlation coefficient of 0.09 for clustering within facili-
ties as observed in DEOLD, we prefer the larger number 
of 8 nursing homes per group, and 12 residents per facility, 
totalling 192 residents. These numbers will suffice to test 
associations with mediators which are at least medium 
in strength.93 Our aim of 192 residents will also suffice 
for subsequent testing of moderators. Finally, as a rule of 
thumb, with 192 residents, we can test between 12 and 19 
covariates per analysis. In all, with these conservative esti-
mates, power is large to very large to detect the expected 
medium to large effect sizes.
Analysis plan
Analyses of effects on primary outcomes
All analyses will be undertaken by intention to treat at both 
the nursing home and patient level. Differences between 
the intervention and control group in characteristics of resi-
dents and sites at baseline will be tested with appropriate 
parametric or non-parametric tests. We will correct for base-
line differences between groups in our analyses. We will test 
if the longitudinal course of quality of life and positive care-
giving experiences differs between the intervention and 
usual care group using mixed linear models that include 
random effects for nursing home and patients nested within 
nursing homes. The models will include fixed effects for 
time and intervention group and their two-way interaction. 
Confounders will be added as main effects. In particular, 
we will adjust for baseline mortality risk using Mitchell’s 
12-month mortality risk score86 and its two-way interaction 
with time so that any missing data due to death during 
follow-up can be considered missing at random. Modera-
tion will be assessed by means of a third-order interaction 
between time, intervention group and the moderator with 
models containing all lower-order terms. Mediation will be 
assessed using Structural Equation Modelling.
Analyses of effects up to in the last phase of life
Because the Namaste Care Family programme includes 
end-of-life care, we expect that effects persist until death 
(and afterwards for family caregivers, affecting family grief). 
For this, we will include specific outcomes, such as comfort 
in the dying phase. We will follow an estimated proportion 
of 70% of residents until death, based on survival curves 
of patients with severe dementia enrolled in the DEOLD 
study who have resided in the nursing home for some more 
than a year on average.55 We will obtain primary and other 
outcomes after death (referring to the period shortly before 
death). End-of-life outcomes will be compared between 
persons who die within 12 months in the intervention and 
usual care group using a mixed model with random effect 
for nursing home and a fixed effect for intervention group.
Cost-effectiveness
We will perform an economic evaluation from a societal 
perspective. Both cost-effectiveness and cost-utility anal-
yses will be performed with a time horizon of 12 months. 
Discounting of costs and effects is not necessary since 
follow-up is limited to 12 months.87 Incremental costs per 
1-unit decrement on the QUALID scale, per QALY and per 
1-unit increment on the PES scale will be estimated. Sensi-
tivity analyses will assess the robustness of the results using 
different assumptions regarding costs and effects including 
different ways to account for family caregiving time. We 
will assess the level of implementation of the Namaste Care 
Family programme in relation to outcomes as well as costs.
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Multiple imputations techniques will be used to handle 
missing cost and effect data. Incremental cost-effectiveness 
ratios (ICERs) will be calculated by dividing the differ-
ence in mean total costs between the treatment groups by 
the difference in mean effects. Bootstrapping with 5000 
replications will be used to estimate 95% CIs around cost 
differences and the uncertainty surrounding the ICERs. 
Cost-effectiveness planes will graphically present uncer-
tainty surrounding the ICERs. We will estimate cost-effec-
tiveness acceptability curves to show the probability that the 
intervention is cost-effective in comparison with usual care 
for a range of different ceiling ratios.94 If appropriate, anal-
yses will be adjusted for confounders or moderators that 
modify the effect.
Process evaluation and analyses
A mixed-method approach will be used for the process 
evaluation. The process evaluation includes qualitative 
semistructured interviews after 12 months with nursing 
staff, managers, family caregivers and volunteers focusing 
on feasibility, accessibility and sustainability. We will analyse 
interviews by open and selective coding of content, with 
two researchers, independently. Triangulation of interviews 
that present different perspectives is used. We will also map 
barriers and facilitators of implementation.
EthICs And dIssEMInAtIon
Most participants will have advanced dementia, although 
some can have moderate dementia with challenging 
behaviour and may therefore respond well to the Namaste 
Family Care programme (accordingly, behavioural symp-
toms of dementia are hypothesised as a moderator in 
table 1). Written consent will therefore be obtained from 
the primary family caregiver. If judged by the researcher 
and/or nursing home as being able to understand informa-
tion about the study and make an informed decision about 
participation, the person with dementia will be asked to 
provide written consent as well.
dissemination
We will publish our findings in peer-reviewed scientific jour-
nals and present results at relevant conferences within the 
field. A symposium for healthcare professionals working in 
long-term care, policy-makers and health insurers will be 
organised. The aim will be to inform and motivate attendees 
to improve the lives of people with advanced dementia 
and their families in the Netherlands. We will develop an 
informative short film about the Namaste Care Family 
programme which includes interviews with nursing staff, 
family caregivers and volunteers about their experiences 
with the programme. Based on the results of the process 
evaluation, an improved version of the Namaste manuals 
will be developed. We will also offer the homes randomised 
to the usual care group the opportunity to implement the 
Namaste Care Family programme at the end of the study. 
This may serve as a pilot test for rolling out the Namaste 
Care Family programme more widely in the Netherlands if 
appropriate. The manuals will be made available to inter-
ested healthcare professionals, organisations and individual 
families and volunteers. The train-the-trainers concept will 
retain experienced families and volunteers for further 
implementation.
In the future, more people with dementia will be expected 
to stay and die at home. Therefore, connecting to people 
with dementia and managing behavioural symptoms of 
dementia at home are also very important goals for family 
caregivers and people with dementia. The application of 
the Namaste Care Family programme in a home setting 
might be a useful intervention to provide in this setting. 
Based on our experiences with Namaste Care Family in 
nursing homes, we will develop a Namaste Care Family 
manual and training for use at home and will conduct a 
pilot study examining the feasibility of the programme 
for people with dementia living at home and their family 
caregiver(s). People with advanced dementia may be able 
to stay at home longer with less challenging behaviour, 
lower caregiver burden and more positive family caregiving 
experiences.
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